One of these new medicines, Fasenra, is approved for people with severe eosinophilic asthma who do not get enough benefit from other medicines. Asthma is a long-term (chronic) condition of the ...

The Food and Drug Administration (FDA) has approved Fasenra ® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). Study participants were ...

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart to treat patients with severe asthma, the IL-5 inhibitors have engaged in a spirited market battle, with one key ...

AstraZeneca’s Fasenra (benralizumab) met its primary endpoint in the MANDARA trial by demonstrating non-inferiority to the current standard of care, GSK’s Nucala (mepolizumab), in patients ...

Fasenra (benralizumab) is a brand-name subcutaneous injection that’s prescribed for severe eosinophilic asthma in certain people. Fasenra hasn’t been reported to interact with alcohol, other ...

September 18, 2024--(BUSINESS WIRE)--AstraZeneca’s FASENRA® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).

Ever since people figured out that the Raspberry Pi 4 has a PCIe bus, the race was on to be the first to connect a regular PCIe expansion card to a Raspberry Pi 4 SBC. Now [Zak Kemble] has created ...

Last week we saw the announcement of the new Raspberry Pi Zero 2 W, which is basically an improved quad-core version of the Pi Zero — more comparable in speed to the Pi 3B+, but in the smaller ...

(RTTNews) - AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with ...

Ruud Dobber, Executive Vice President, BioPharmaceuticals Business Unit, AstraZeneca said: “FASENRA is already well established for the treatment of severe eosinophilic asthma, and with this ...